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Received 18 December 2009; received in revised form 2 March 2010; accepted 20 April 2010Abstract Human embryonic stem cells (hESCs) are a promising source of oligodendrocyte precursor cells (OPCs) and
oligodendrocytes. These cells can be used to repair myelin in central nervous system deficits such as multiple sclerosis or
traumas such as spinal cord injury. Here, we introduce a novel differentiation method for the production of OPCs from hESCs.
OPCs were differentiated as spheres in defined serum-free medium supplemented with recombinant human growth factors. A
broad gene expression analysis revealed that this OPC population expressed Olig1/2, Sox10, PDGFR, Nkx2.2, Nkx6.2,
oligodendrocyte-myelin glycoprotein, myelin basic protein (MBP), and proteolipid protein (PLP). According to quantitative RT-
PCR analyses addition of ciliary neurotrophic factor (CNTF) upregulated the Olig2mRNA levels in the OPC population. According
to the flow cytometry analyses the OPC population was N90% NG2-positive, N80% PDGFR-positive, and N60% CD44-positive, and
further matured into O4- (45%) and GalC- (80%) positive oligodendrocyte populations when cultured on top of human
extracellular matrix proteins, which were used instead of Matrigel. In addition, OPCs matured into myelin-forming cells when
cocultured with neuronal cells. The multilayered myelin sheet formation around axons was detected with transmission electron
microscopy in cocultures. Further, the OPC populations could be purified with sorting of NG2+ cells. These NG2+ cells reformed
spheres that remained stable during prolonged culturing (7 weeks), and matured into GalC-positive oligodendrocytes.
Importantly, these NG2+ spheres were free of pluripotent Tra1-81, Oct-4, and CD326-positive hESCs. Thus, this method is
suitable for the efficient production of OPCs and in the future for therapeutic graft production.
© 2010 Elsevier B.V. All rights reserved.Introduction
Oligodendrocyte precursor cells (OPCs) develop from neural
stem cells through various genetic and morphologic stages
(Nicolay et al., 2007). OPCs migrate from the germinal zones
into the brain parenchyma where they mature into oligoden-
drocytes (Miller, 2002; Spassky et al., 2001). OPCs develop⁎ Corresponding author. Fax: +358 3 3551 8498.
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doi:10.1016/j.scr.2010.04.005from bipolar cells and express genes such as Olig1/2, Sox10,
and Nkx2.2 (Hu et al., 2009), and specific proteins, such as
chondroitin sulfate proteoglycan (NG2) and platelet-derived
growth factor receptor-α (PDGFRα) (Levine et al., 2001;
Nishiyama et al., 1996). Maturing OPCs express the myelina-
tion-related genes Nkx6.2, myelin basic protein (MBP), and
proteolipid protein (PLP), and proteins such as galactocer-
ebroside (GalC), O4, and MBP (Nicolay et al., 2007). The
major function of oligodendrocytes is to form myelin sheets
around axons to protect and enhance neuronal signaling.
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demyelination in central nervous system (CNS) deficits such
as multiple sclerosis, spinal cord injury (SCI), and brain
injury. There are currently no effective treatments for these
CNS deficits. Oligodendrocyte-based transplantation repre-
sents a potential treatment option.
Human OPCs can be obtained from aborted fetuses
(Zhang et al., 2000), olfactory biopsies of the neuroepithe-
lium (Zhang et al., 2005), and differentiated human
embryonic stem cells (hESCs) (Hu et al., 2009; Izrael et
al., 2007; Nistor et al., 2005; Zhang et al., 2006b). hESCs are
clinically the most attractive material for OPC production
due to their high proliferation potential and differentiation
capacity (Nistor et al., 2005; Thomson et al., 1998).
Compared to mouse ESC-derived OPCs (Brustle et al.,
1999; Glaser et al., 2005; Zhang et al., 2006a), the
production of hESC-derived OPCs is less straightforward
and most attempts to transfer mouse ESC methods to hESC
cultures have failed (Izrael et al., 2007). Nevertheless,
hESCs do differentiate into OPCs and these cells have been
shown to restore locomotor function and increase myelina-
tion in SCI rats (Keirstead et al., 2005) and restore
myelination in the shiverer mouse brain (Izrael et al.,
2007). Thus, the development of methods to efficiently
differentiate hESCs into OPCs especially for clinical pur-
poses is urgently needed to expand treatment options for
patients with CNS disorders.
Current protocols for OPC differentiation from hESCs use
animal-derived components like Matrigel and animal-derived
growth supplements (Izrael et al., 2007; Nistor et al., 2005;
Zhang et al., 2006b). In addition, most hESC lines are
cultured on mouse fibroblasts, which may contaminate the
cultures and cause immunologic responses (Heiskanen et al.,
2007; Martin et al., 2005). In addition, commonly used
enzymatic passaging of hESCs tends to increase the incidence
of abnormal chromosomal mutations (Thomson et al., 2008),
which can lead to development of cancer cells. Some neural
differentiation methods utilize either stromal cell lines (MS5
and PA6) or Matrigel (Carpenter et al., 2001; Nistor et al.,
2005; Reubinoff et al., 2001; Zhang et al., 2001), both of
which increase the risk of pathogen cross-transfer. Despite
this, the first Phase I clinical trial on spinal cord injury
patients using hESC-derived oligodendrocyte progenitor cells
(GRNOPC1) will be conduct by Geron in the near future. The
cells differentiation protocol is based on the Nistor and
colleagues method (2005) and contains several animal
derived components and Matrigel (Nistor et al., 2005).
Currently the study has been placed on clinical hold by the
FDA pending data from a nonclinical animal study which
showed cystic formation in spinal cords of the transplanted
animals (www.geron.com). This implies that obtaining hESC-
derived cell populations for clinical trials is a time-
consuming and complicated process where the safety of
the cell grafts must be clearly proved. Thus, differentiation
methods that aim for xeno-free cell production with detailed
cell population characterizations and purification steps are
crucial en route to clinics.
Here, we introduce a new method for OPC differentiation
from hESCs. First, the hESCs used for OPC production were
cultured on human feeder cells, passaged mechanically, and
grown in serum-free media. Second, OPCs were differenti-
ated in suspension culture and passaged mechanically in thepresence of human recombinant growth factors andmitogens
in serum-free media. Third, the cells were matured without
Matrigel on human extracellular matrix (ECM) proteins.
Fourth, OPC populations were purified by fluorescence-
activated cell sorting using NG2-antibody.
Results
HESC oligodendrocyte differentiation
Two hESC lines, HS360 and HS362, were used to develop the
oligodendrocyte differentiation protocol. The entire three-
stage differentiation protocol took 13 weeks to complete
(Fig. 1). In Stage 1 hESCs differentiated into neural
precursors in neural spheres in suspension culture. These
neural spheres were cultured for 4 to 8 weeks in the presence
of bFGF, EGF, and CNTF. In Stage 2, the OPCs were
differentiated in suspension culture for 3 weeks in the
presence of bFGF, EGF PDGF-AA, laminin, ± CNTF, or± IGF-
1. In Stage 3, the OPCs were matured in suspension culture
for 2 weeks in the presence of T3, ± CNTF, or±AA.
Gene expression profiles of developing OPCs
The hESC-derived differentiating OPCs were analyzed
with semiquantitative RT-PCR at 0, 4, 8, 11, and 13 weeks
(Figs. 2A–C). Gene expression analysis showed that the
undifferentiated hESCs (HS360 and HS362) expressed the
pluripotent gene Oct-4 which was downregulated during
differentiation. Expression of the neural precursor gene
Nestin was constant during Stages 1 and 2 (0–11 weeks;
Fig. 2A), whereas expression of the neural precursor gene
Pax-6 was downregulated in Stage 2 (11 weeks; Fig. 2A).
Sox10 and Olig2 were expressed during OPC differentiation
Stages 1 to 3 (4–13 weeks; Fig. 2B). Especially at Stage 3
Olig2 was expressed in cells cultured in Medium 3.2,
containing T3, CNTF, and AA (13 weeks; Fig. 2B). More
detailed gene expression analysis of the hESC line HS362
revealed that during Stage 1 (4 weeks), neural precursor
gene Mash1, and OPC gene Olig1, and oligodendrocyte-
myelin glycoprotein (OMG) were expressed (Fig. 2C). Up to
8 weeks was required, however, before a neural to glial cell
switch was confirmed by the upregulation of Ngn3 and Sox9.
Also, the expression of PDGFR, Nkx2.2, Nkx6.2, andMBPwas
detected and the expression of Sox8 was upregulated after
8 weeks (Fig. 2C). After Stage 2 (11 weeks), the gene
expression patterns in the OPC populations varied to some
extent depending on the growth factor composition of the
medium. Olig1 and Nkx2.2, however, were upregulated in
cells grown in medium containing IGF-1 and CNTF (Medium
2.2.). When cells grown in this medium were advanced to
Stage 3 for further maturation, and cultured in growth
factor-reduced media containing T3, ± CNTF, or±AA, the
gene expression patterns changed considerably (13 weeks;
Fig. 2C). In particular, Gli1, Gli2, Sox9, Sox10, Olig1,
Nkx2.2, and Nkx6.2 were strongly upregulated in the
presence of T3, CNTF, and AA-treated cells (Medium 3.2,
Fig. 2C), indicating that the combination of these factors
supports OPC maturation. According to qRT-PCR analysis at
Stage 2 (11 weeks), the Olig2 expression increased in OPCs
treated with CNTF (Media 2.1 and 2.2) compared to cells
Figure 1 A schematic representation of the differentiation of hESC-derived OPCs (A). RT-PCR analysis of the differentiating spheres
was performed at Stage 1 (4 and 8 weeks), Stage 2 (11 weeks), and Stage 3 (13 weeks). The morphologic analysis and collection of
samples for the flow cytometric (FC, time points 5, 9, 12, and 13 weeks), immunocytochemistry (ICC; 5, 9, 12, and 13 weeks), cell
proliferation (5′-bromo-2-deoxyuridine, BrdU, 12 weeks), cell viability (Live/Dead, 12-weeks), and cell sorting (12 weeks) were
performed after 1 week of adherent culturing (AC). Morphology of cells during differentiation stages is presented (B–D, scale
bar=50 µm). The medium additives at different stages are presented in (E). In Stage 1, the hESCs differentiated to neural precursors in
suspension culture in the presence of EGF (epidermal growth factor), bFGF (basic fibroblast growth factor), and CNTF (ciliary
neurotrophic factor)=Medium 1. In Stage 2, the cells were induced to differentiate into OPCs in the presence of bFGF, EGF, PDGF-AA
(platelet-derived growth factor-AA), laminin, ± CNTF, and± IGF-1 (insulin-like growth factor-1)=Media 2.1–2.4. In Stage 3, the OPCs
differentiated further in the presence of T3 (3,3′,5-triiodo-L-thyronine), ± AA (L-ascorbic acid 2-phosphate), and±CNTF=Media 3.1–
3.3 (E). In the adherent cultures, cells were grown in the presence of bFGF, EGF, PDGF-AA, laminin, CNTF, and IGF-1 (5-, 9-, and 12-
week samples) or in the presence of T3, AA, and CNTF (13-week samples).
93Oligodendrocyte precursors derived from hESCscultured without CNTF (Media 2.3–2.4, Figs. 2D and E). At
Stage 3 (13 weeks), in the presence of T3, CNTF, and AA,
Olig2 expression was increased (Medium 3.2, Figs. 2D and E).
Olig2 induction was confirmed with two different hESC lines
(HS360 and HS362, Figs. 2D and E).
Immunocytochemical characterization of
developing OPCs
Immunocytochemical staining patterns showed that OPCs
(Stage 2, 12 weeks) expressed NG2, Olig2, PDGFR-α,
(Figs. 2F–H). These OPC populations were proliferative and
stained positive for BrdU marker (Fig. 2H). Prematuring GalC-
positive cells were dividing and expressed Ki67 (Fig. 2I). At
Stage 3 (13 weeks), the maturing OPCs coexpressed NG2 and
O4 (Fig. 2J) and were highly positive for GalC (Figs. 2K–M) and
coexpressed MBP (Fig. 2M), a major protein involved in the
myelination process. Further, the produced population had
typical morphologic characteristics of oligodendrocytes (Sup-
plemental Movie).Effects of IGF-1 on OPC proliferation and survival
in vitro
IGF-1 is shown to be crucial for OPC survival (Cui et al., 2005;
Ness et al., 2004; Pang et al., 2007). Here, we studied the
effect of IGF-1 on the proliferation and survival of OPCs at
Stage 2 (12 weeks). After 3 weeks of culturing in the
presence or absence of IGF-1, the OPCs were stained for
NG2 and BrdU (Figs. 3A–D), and the number of colabeled
cells was counted for each medium. The results indicated
that IGF-1 significantly increased cell proliferation by 24
percentage unit (Pb0.01, HS362) and 20 percentage unit
(Pb0.05, HS360) in the presence of CNTF (Medium 2.2) but
did not have constant effect without CNTF (Medium 2.4,
Fig. 3E). Then we evaluated the effect of IGF-1 on cell
survival. The numbers of live and dead cells were counted for
each medium (Figs. 4F–I). IGF-1 increased the number of
living cells from 16 to 23 percentage unit in the presence of
CNTF (16 percentage unit, Pb0.05, HS360-derived OPCs and
23 percentage unit Pb0.01, HS362-drived OPCs; Fig. 3J). No
Figure 2 Gene expression analyses in hESC lines HS360 and HS362 during OPC differentiation (A, B). Pluripotent hESC marker Oct-4
was expressed in undifferentiated hESCs, neural markers Nestin and Pax-6 were expressed constantly during differentiation, and
GAPDH was used as a housekeeping gene (A). Sox10 and Olig2 (OPC markers) were expressed during differentiation Stages 1–3 (B).
Wider gene expression analysis of OPC differentiation of hESCs (HS362) in Stages 1–3 is presented (C). Quantitative RT-PCR analysis of
Olig2 showed upregulation of Olig2 in the presence of CNTF in Stage 2 and in Stage 3. Undifferentiated hESCs were used as a reference
sample and GAPDH as a reference gene (hESC lines HS360 and HS362, D, E). Medium additives: hES=bFGF; Medium 1=EGF, bFGF,
CNTF; Medium 2.1=EGF, bFGF, PDGF-AA, laminin, CNTF; Medium 2.2=EGF, bFGF, PDGF-AA, laminin, CNTF, IGF-1; Medium 2.3=EGF,
bFGF, PDGF-AA, laminin; Medium 2.4=EGF, bFGF, PDGF-AA, laminin, IGF-1; 3.1=T3, CNTF; Medium 3.2=T3, CNTF, AA; Medium
3.3=T3, AA. Immunocytochemical characterization of hESC-derived OPCs and oligodendrocytes (hESC line HS360, F–M). OPCs in Stage
2 were positive for NG2 (green, F) and Olig2 (red, G). Proliferating OPCs were positive for PDGFR (green) and BrdU (red, H) and positive
for GalC (red) and Ki67 (green, I). Maturing oligodendrocytes in Stage 3 were positive for O4 (red, J). Mature oligodendrocytes were
positive for GalC (red, K–M) and expressed MBP (green, M), which accumulated in the branches of oligodendrocytes. Scale bars:
100 µm (F), 50 µm (G), 50 µm (H), 50 µm (I), 50 µm (J), 100 µm (K), and 50 µm (L–M).
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Figure 3 Effects of IGF-1 on cell proliferation at Stage 2 (12 weeks) were studied with hESC lines HS360 and HS362 (A–E). BrdU-
positive cells (red) in a NG2-positive cell population (green); cells were cultured with+CNTF/–IGF-1 (Medium 2.1, A), +CNTF/+IGF-1
(Medium 2.2, B), –CNTF/–IGF-1 (Medium 2.3, C), and –CNTF/+IGF-1 (Medium 2.4, D). Cell proliferation significantly increased after
IGF-1 stimulation (* Pb0.01, ** Pb0.05, results are means±SD, n=5–18/group) (E). Effect of IGF-1 on cell survival at Stage 2
(12 weeks, F–J). Fluorescent pictures of live cells (green) and dead cells (red), cells were treated with+CNTF/ –IGF-1 (Medium 2.1,
F), +CNTF/+IGF-1 (Medium 2.2, G), –CNTF/–IGF-1 (Medium 2.3, H), and –CNTF/+IGF-1 (Medium 2.4, I). Cell viability study indicated
that cell survival increased when cultures were treated with IGF-1 and CNTF (* Pb0.01, ** Pb0.05, results are means±SD, n=8–10/
group, J). Scale bar, 100 µm.
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with IGF-1 in the absence of CNTF (Fig. 3J). These results
indicated that Medium 2.2 containing both IGF-1 and CNTF
provided the best support for OPC proliferation and survival.Expression of oligodendrocyte-specific proteins
during OPC differentiation
The protein expression analysis of differentiating OPC
cultures was performed using immunocytochemical cell
counts and flow cytometry. Prior to analyses, cells from
Stages 1 (8 weeks) and 2 (11 weeks) were cultured for 1 week
in adherent cultures in Medium 2.1, 2.2, 2.3, or 2.4.Immunocytochemical cell counts revealed that after 1 week
of differentiation (9 weeks) cells were 43 to 55% positive for
NG2 (Supplemental Table 2) and 90 to 93% NG2 positive in
Stage 2 (12 weeks, Supplemental Table 2). Expression of
PDGFRα increased from 28 to 73% in Stage 1 (9 weeks) and
from 86 to 88% in Stage 2 (12 weeks; Supplemental Table 2).
After Stage 2 the OPC population could be cryo-preserved and
after thawing remained viable and were N90% NG2 positive
(data not shown). Importantly, astrocytes and neurons were
either not detected or present in low numbers during the OPC
differentiation (Supplemental Table 2, Figs. 4B and D). For
further OPC differentiation Medium 2.2 was chosen and
Figure 4A shows the upregulation of NG2 (N90%) and CD44
(N60%) expressions in HS360- and HS362-derived OPCs at
Figure 4 Flow cytometry analysis of CD44, NG2, and O4 expression during OPC differentiation from two independent experiments of
two hESC lines (HS360 and HS362, A). Expression of GFAP and MAP2 during OPC differentiation (hESC line HS362, B). Expression of GalC-
positive cells during OPC differentiation in Stages 2 and 3. Results are combined means±SD from two cell lines studied (HS360 and
HS362, n=12–16/group, C). At Stage 3, only a few cells expressed GFAP (red) and MAP2 (green, D) whereas most of the cells were
GalC-positive (red, E) (hESC line HS362). Scale bar, 100 µm.
96 M. Sundberg et al.Stage 2 (Fig. 4A). In the maturing OPCs at Stage 3 the
expression of NG2 and CD44 was decreased, while expression
of O4 increased up to ∼45% compared to ∼20% expression at
Stage 2 (Fig. 4A). Similarly, the amount of GalC-positive cells
significantly increased up to ∼80% in the maturing OPC
population at Stage 3 compared to Stage 2 (Pb0.001, Figs. 4C
and E). Detailed expression of GalC at Stage 3 is presented in
Supplemental Table 3.Expression of CD44 during oligodendrocyte
differentiation
As the flow cytometric analysis indicated relatively high
expression of CD44 at Stage 2 during OPC differentiation
(∼60%, Fig. 4A), it was examined in more detail. The
combinatorial flow cytometric analysis revealed that during
further differentiation at Stage 3, the CD44-positive cells
coexpressed NG2 (Supplemental Fig. 1A), whereas only a few
of O4-positive cells were CD44-positive (Supplemental
Fig. 1C). On the other hand, NG2-positive cells coexpressed
O4 (Supplemental Fig. 1B). The coexpression of CD44 and
NG2 was confirmed by immunocytochemical staining (Sup-
plemental Fig. 1D). In addition, PDGFRα and Olig2-positive
OPCs, BLBP-positive radial glial cells, and GFAP-positive
astrocytes expressed CD44 to some extent (Supplemental
Figs. 1E–I). On the other hand, the maturing GalC-positiveoligodendrocytes did not express CD44 (Supplemental
Fig. 1G). These results suggest that CD44 is expressed in
radial glial cells, astrocytes, and OPCs, but not in maturing
oligodendrocytes.
Myelination capacity of OPCs
OPCs from Stage 2 were cocultured with GFP neurons. The
OPCs differentiated into pre- and myelinating oligodendro-
cytes, positive for GalC which aligned along neurites
(Supplemental Fig. 2A). Further, the oligodendrocytes
attached to the neurons (Supplemental Fig. 2B) and formed
MBP-positive wraps around the neurites (Supplemental
Fig. 2C). Scanning electron microscopy analysis revealed
ramification of cell branches of maturing oligodendrocytes in
single and cocultures (Figs. 5A and B). Myelination capacity
of oligodendrocytes (from Stage 3) was detected with
transmission electron microscopy, which showed myelin
sheets around multiple axons (Figs. 5C–E). Higher magnifi-
cation revealed the formation of multilayered myelin sheath
around axons (Figs. 5D and E).
Sorting of NG2+ OPC populations
After Stage 2 (11 weeks), OPCs positive for NG2 were sorted
(Fig. 6A and B). After 1 week of subculturing and the NG2+
Figure 5 Scanning electron micrographs (SEM) of maturing hESC-derived OPCs (A), and coculture of OPCs with neurons (hESC line
Regea 06/040, B). The transmission electron micrograph illustrates myelination of axons in cocultures (C); higher magnification of
multilayered myelin sheaths around the axons (D, E). Arrow indicates the myelin layers (E). Scale bar, 10 µm.
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40% of Ki67-positive cells) when cultured with a B27
supplement (Figs. 6C and D). In addition, NG2+ cells after
7 weeks of subculturing expressed higher levels of NG2 and
O4 when cultured with B27 compared to cells cultured
without it (Fig. 6G). Thus, for prolonged subculturing and
sphere formation B27 was added to media as described
earlier (Jiang et al., 2009). The NG2+ cells aggregated into
spheres already at 4 to 8 days after sorting and were
mechanically passaged once a week thereafter (Fig. 6E).
The NG2+ spheres had a stable oligodendrocyte-related gene
expression profile during the 2- to 6-week follow-up time,
and expression of Oct4 could not be detected (Fig. 6F).
Compared to unsorted cell population, 2 and 4 weeks after
sorting the expressions of NG2, PDGFR, Olig2, Nkx6.2, and
PLP were stronger in NG2+ cells (Fig. 6F). Flow cytometry
analysis revealed that the sorted cell population remained
NG2+ during 7 weeks of subculturing compared to an
unsorted cell population at the same time point (Fig. 6G).
In addition, NG2+ cells expressed N50% O4 (Fig. 6G), whereas
unsorted cells were b20% O4 positive. Importantly, NG2+
cells were negative for pluripotency markers Tra1-81 and
Oct-4 (Fig. 6H) and for CD362 (Fig. 6I). After 7 weeks of
subculturing NG2+ cells differentiated into GalC-positive
cells (Fig. 6K). The amount of proliferating cells decreased
after prolonged subcultivation of NG2+ spheres, compared to
1 week after sorting (Figs. 6L and C). All cultures were freeon neuronal cells, whereas few GFAP-positive astrocytes
were detected (Fig. 6M).Discussion
To date, the protocols developed for OPC differentiation
from hESCs contain animal-derived substances and therefore
are not designed as such for clinical grade production (Izrael
et al., 2007; Kang et al., 2007; Nistor et al., 2005). Despite
this, attempts to transform these methods for graft produc-
tion for clinical trials are ongoing (Geron Corporation, USA),
although contents and safety issues of these products are not
fully characterized. Here, we introduced a novel method for
human OPC production from hESCs using human recombinant
growth factors and ECM proteins. This protocol comprised 3
stages in same basal medium with different growth factor
cocktails. Further, this method was based on the sphere
formation in suspension culture with mechanical passaging.
Mechanical passaging allows large-scale OPC production and
cell amplification in vitro. In the future, it will be possible to
transfer these suspension cultures to bioreactor cultivation,
where gas flows, medium changes, and cell passaging are
performed under invariable conditions under computer
monitoring (Gilbertson et al., 2006; Portner et al., 2005;
Sen et al., 2004). The entire differentiation procedure took
13 weeks to complete and during Stage 2 the proliferating
Figure 6 Characterization of sorted NG2+ cells (hESC lines Regea 06/040 and Regea 08/023). FSC/SSC dot plot shows determination
of OPC population (A). FITC-histogram shows that 76% of cells were NG2+ (red); unstained cells were used for background
determination (black, B). Subcultured NG2+ cells expressed Ki67; 48% if cultured with B27 (green, C), and 40% if cultured without B27
(green, D), in Medium 2.2. Eight days after sorting, NG2+ cells formed round and solid spheres in suspension culture (E). Gene
expression analyses of cells before sorting (Stage 2, 11 weeks), NG2+ cells (2, 4, and 6 weeks after sorting), and not sorted cells (2, 4,
and 6 weeks) are presented (F). Seven weeks after sorting the NG2+ and not sorted cell population, cultured with or without B27, were
analyzed with flow cytometry for expression of NG2 and O4 (G). NG2+ cells were negative for Tra-1-81 (red, H) and Oct-4 (green, H)
and only 0.4% CD326-positive after 7 weeks of subculturing in Medium 2.2 (I). Undifferentiated hESCs were used as a positive control
for the staining with pluripotency marker CD326 (J), and unstained cells were used for background determination (blue, I, J). In vitro
differentiated NG2+ cells (7 weeks time point) expressed GalC (red K), NG2 (green, K), Ki67 (green, L), and GFAP (red, M), but did not
express MAP-2 (green, M). Scale bars, 100 µm.
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demonstrated that the sorted OPCs formed pure NG2+
spheres that remained stable during prolonged culturing.
Previously published methods for hESC-derived OPC
differentiation comprise 5 to 6 stages (6 to 7 weeks long)
with growth factor stimulation and withdrawal (Izrael et al.,
2007; Kang et al., 2007; Nistor et al., 2005) and thus cannot
be directly compared with the three-stage 13-week-long
protocol described here. Our protocol contains, however, along neural induction stage (8 weeks) for effective cell
population amplification which can be shortened by half to
4 weeks. Recently, Hu and colleagues (2009) described also a
13-week-long protocol for human OPC differentiation (Hu
et al., 2009). As human developmental processes are much
more complex than in rodents, for example, longer protocols
are required for human OPC production. Compared to
previously published methods describing hESC-derived OPC
production our medium composition is most similar to that of
99Oligodendrocyte precursors derived from hESCsKang and co-workers, who used DMEM/F12 with N2 and FGF
for the initial neural differentiation (Kang et al., 2007). In
addition to FGF, we added EGF and CNTF for the initial
neural differentiation which are known factors to increase
differentiation of both neural and glial cells (Kulbatski and
Tator, 2009). Sphere formation was initiated directly in
neural medium, without initial embryoid body (EB) forma-
tion, as previously described for hESCs in neuronal induction
(Nat et al., 2007). For OPC production at stage 2, in addition
to PDGF-AA, EGF, and bFGF used by Kang and co-workers
(2007), we added CNTF and IGF-1. CNTF is known to enhance
differentiation and maturation of OPC cultures (Rivera et al.,
2008) and IGF-1 increases the survival, proliferation, and
differentiation of OPCs and oligodendrocytes in rodents
(Barres et al., 1993; Hsieh et al., 2004; Zaka et al., 2005). In
the present study, we showed that CNTF induced Olig2
expression in OPCs at Stage 2, which is a novel finding of
CNTF effects on OPC differentiation. Olig2 expression has
shown to be essential for OPC specification (Hu et al., 2009).
In addition, we showed that at Stage 2 IGF-1 increased the
amount of proliferating NG2-positive cells and, together with
CNTF, increased cell survival, as previously demonstrated in
rodent OPCs (Barres et al., 1992; Carson et al., 1993;
McMorris and Dubois-Dalcq, 1988). Further, IGF-1 and CNFT
together increased the expression of Nkx2.2. We did not use
exogenous sonic hedgehog (Shh) in our protocol as previously
reported (Hu et al., 2009). Despite this, we detected
upregulation of the Shh mediator Gli1 (Dakubo et al., 2008)
and thus we suggested that developing OPCs have endoge-
nous Shh signaling. In the last stage of differentiation, T3,
CNTF, and AA were added to the cultures. It is known that T3
as well as CNTF enhances the maturation of rodent OPCs
(Dugas et al., 2007; Rivera et al., 2008), and AA upregulates
the expression of the myelination-related genes PLP and
MAG in glioma cell line (Laszkiewicz et al., 1992). According
to our results, a combination of all these 3 factors together
enhanced expression of oligodendrocyte-related genes in
maturing OPCs and increased the amount of GalC-positive
cells up to 80% in Stage 3 compared to 40% expression in
Stage 2.
In contrast to all of the previous methods (Izrael et al.,
2007; Nistor et al., 2005) we derived OPCs without Matrigel
adhesion. Instead, the differentiation was performed on a
human ECM protein surface containing laminin, collagen IV,
and nidogen-1. This composition was chosen because laminin
receptors are important for OPC survival, maturation, and
myelination (Colognato et al., 2002, 2007) and nidogen-1
acts as a bridge between laminin-1 and collagen IV and
facilitates laminin-1 signaling (Pujuguet et al., 2000). We
suggest that this human ECM protein cocktail is sufficient for
OPC culturing and differentiation and thus enables removal
of Matrigel, an animal-derived component, from the
protocol.
To monitor hESC-derived OPC differentiation, we per-
formed a wider oligodendrocyte-related gene expression
analysis compared to any previous study (Izrael et al., 2007;
Kang et al., 2007; Nistor et al., 2005; Zhang et al., 2006b).
Consistent with previous studies (Izrael et al., 2007; Kang
et al., 2007), the expression of PDGF-R, Nkx2.2, Sox10,
Olig1/2, MBP, and PLP was upregulated. In addition, the
expressions of Ngn3, Sox9, Sox8, Gli1, Gli2, Nkx6.2, and
oligodendrocyte-myelin glycoprotein, genes crucial foroligodendrocyte development (Nicolay et al., 2007), were
also upregulated in hESC-derived OPCs. Recently, Hu and
colleagues reported the importance of Olig2 in OPC
development (Hu et al., 2009), and in line with this, we
showed that the developing OPCs were positive for Olig2
using quantitative RT-PCR. Further, Sox9, Sox8, and Sox10
were upregulated in our cells. Sox9 promotes the switch from
neurogenesis to oligodendrogenesis with Sox8 and Sox10
(Stolt et al., 2003). Sox10 expression was detected in neural
precursor and in maturating OPCs as shown previously by
Izrael and co-workers (2007). Further, the mediators of Shh
signaling in neural stem cell development, Gli1 and Gli2
(Matise and Joyner, 1999; Qi et al., 2003), were constantly
expressed in developing OPCs. The myelination-related
genes PLP and MBP were expressed in the final stage of our
differentiation protocol, consistent with a previous report
(Kang et al., 2007). Also, the expression of Nkx2.2 and
Nkx6.2, known controllers of PLP expression (Awatramani
et al., 2000; Qi et al., 2001), were detected in the final
stage. In particular, Nkx6.2 activates myelin gene expression
by binding MBP promoter regions, and is required for normal
myelin formation (Southwood et al., 2004). Thus, the
expression of these genes suggests that the maturing OPC
population is capable of forming myelin.
The hESC-derived OPCs were positive for NG2 and
PDGFRα, two markers routinely used to identify OPCs (Levine
et al., 2001; Nishiyama et al., 1996). According to flow
cytometry and immunocytochemical analysis, the OPC
population after Stage 2 was more than 80% positive for
NG2 and more than 80% positive for PDGFRα. Further, OPC
from Stage 2 could be cryo-preserved without influencing
their phenotype. In the final stage, Stage 3, the maturing
OPC population coexpressed to some extent precursor
proteins and proteins related to maturation. Thus, we
suggest that there exists a transition stage of prematuring
OPCs before finally maturated oligodendrocytes, and the
expression of certain precursor markers is not strictly
downregulated but they are slowly fainting during differen-
tiation. At Stage 3, the cells were more than 45% positive for
O4, and more than 80% positive for GalC. These results are
quite similar to those of previous study (Kang et al., 2007).
Taken together, the gene expression, immunocytochemical,
and flow cytometry analyses confirmed the efficiency of our
protocol for OPC production.
Previously, the myelination capacity of human OPCs has
been demonstrated in vivo with shiverer mice that do not
contain compact myelin (Hu et al., 2009; Izrael et al., 2007;
Nistor et al., 2005). Here, we demonstrated in vitro in
cocultures with neurons that the GalC-positive pre- and
myelinating oligodendrocytes aligned along neurites and
expressed MBP. Electron microscopical analysis revealed
that these cells had highly branched cell processes and the
morphology of mature oligodendrocytes. More importantly,
we showed that maturing oligodendrocytes myelinated axons
with multilayered myelin sheets in cocultures with neurons.
Together, these results confirmed that OPCs developed
according to our method are capable of differentiate into
oligodendrocytes and myelinate neurons.
To produce a pure OPC population, we sorted OPCs with
NG2+ selection. In the earlier studies, rats OPCs were purified
using A2B5-antibody (Barres et al., 1992; Robinson and Miller,
1996) and cultured for long time in the precursor state, using
100 M. Sundberg et al.PDGF-AA and FGF2. However, there are debates among
researchers about the specificity of A2B5 antibody for OPC
detection, because it is also expressed in astrocyte precursor
cells (Mi and Barres, 1999). NG2 is a chondroitin sulfate
proteoglycan, a surface marker detected in OPCs in different
species (Nishiyama et al., 2009;Wilson et al., 2006). According
to previous study, NG2+ cells can give rise to GABAergic
neurons, olfactory interneurons, or oligodendrocytes depend-
ing on region-specific cues in mouse brain (Aguirre and Gallo,
2004; Aguirre et al., 2004). Importantly, rodent glial cell
populations sorted for NG2+ and subcultured in OPC specific
medium did not give rise to neurons in vitro (Horiuchi et al.,
2009). Similar to a previous study with rodent cells, we chose
NG2-antibody for purification of OPC population and cultured
these sorted NG2+ cells for prolonged periods in our OPC-
inducing medium. According to our study, the NG2+ cells were
proliferative after sorting, which is important when large-
scale production of cells is needed. The sorted NG2+ cells
expressed genes and proteins specific for OPC development.
Importantly, the NG2+ cell population was free from pluripo-
tent cells as theywere negative for Tra1-81, Oct-4, and CD326,
known markers for pluripotency (Adewumi et al., 2007; Ng et
al., 2010; Sundberg et al., 2009). This is crucial for safe
nontumorgenic cell population production. The sorted NG2+
population matured into GalC-positive cells and only very few
astrocytes were detected. We suggest that sorting of NG2+
cells is reliable way for OPC population purification. Thus, this
is the first report describing purification of human NG2+ OPCs,
their amplification, prolonged culturing, and differentiation
into oligodendrocytes.
In conclusion, we developed an efficient method for
differentiating human OPCs from hESCs. These OPCs were
differentiated in serum free-media with human-derived
growth factors, mitogens, and human ECM proteins. These
OPCs were able to myelinate neurons in vitro. Importantly,
the formation of NG2+ spheres allowed for amplification of
the pure OPC population in suspension culture, which
remained stable during 7 weeks of culturing in vitro and
further differentiated into GalC-positive cells. Our OPC
differentiation method is suitable for studying the develop-
ment of human oligodendrocytes and an initial start point for
developing xeno-free protocols for future cell graft produc-
tion for demyelination disorders of the CNS.Materials and methods
hESC cultures
The hESC lines (HS360, p59 and p69; and HS362, p93, p100,
and p118) used in the study were kindly provided by Dr. Outi
Hovatta, Karolinska Institute, Sweden. The procedures used
to derive, characterize, and culture the hESC lines were
described previously (Hovatta et al., 2003; Inzunza et al.,
2005). In addition, we used two hESC lines derived at Regea–
Institute for Regenerative Medicine; Regea 06/040 (p35 and
p44) and Regea 08/023 (p73) both listed in European Human
Embryonic Stem Cell Registry (www.hescreg.eu). All the
hESCs were cultured as previously described (Rajala et al.,
2007; Sundberg et al., 2009). See details in supplemental
information.Differentiation of OPCs from hESCs
The hESCs were differentiated into oligodendrocytes as
spheres in a suspension culture in three stages (Fig. 1). The
basal N2 medium used throughout the experiment contained
DMEM/F-12 supplemented with 1X N2 supplement and 2 mM
GlutaMax (both from Gibco Invitrogen), 0.6% glucose, 5 mM
Hepes, 2 µg/ml heparin (all from Sigma, St. Louis, MO), and
25 U/ml penicillin and streptomycin. The suspension
culturing was performed in ultralow cell cluster 6-well
plates (Costar, Corning Inc., Corning, NY) using a three-
stage protocol. Stage 1: Neural precursor production. In the
beginning, hECS colonies were mechanically cut into small
clusters and directly transferred into neural inductor
medium as described earlier (Nat et al., 2007). Differenti-
ating neural cell aggregates were cultured for 4 or 8 weeks in
N2 medium supplemented with 10 ng/ml human ciliary
neurotrophic factor (CNTF), 20 ng/ml human epithelial
growth factor (EGF), and 20 ng/ml bFGF (all purchased
from R&D Systems Europe, Abingdon, UK). Stage 2: Oligo-
dendrocyte precursor production. Cells were cultured for
3 weeks in N2 medium supplemented with 10 ng/ml CNTF,
20 ng/ml EGF, 10 ng/ml bFGF, 100 ng/ml insulin-like growth
factor-1 (IGF-1, Sigma), 20 ng/ml platelet-derived growth
factor-AA (PDGF-AA, Peprotech Inc. Rocky Hill, NJ), and
1 µg/ml laminin (Sigma). Stage 3: Oligodendrocyte precursor
maturation. OPCs were cultured for 2 weeks in N2 medium
supplemented with 200 µM L-ascorbic acid 2-phosphate (AA,
Sigma), 10 ng/ml CNTF, and 40 ng/ml 3,3′,5-triiodo-L-
thyronine (T3, Sigma). Throughout the experiment, the
spheres were dissected mechanically once a week. The
medium was changed 3 times per week. All cultures were
maintained in a humidified atmosphere at 37 °C and 5% CO2.
Fig. 1 shows the experimental design, sample collection
points and used analyses, and description of the used
medium additives.Gene expression analysis
RNA samples were collected directly from the suspension
cultures at Stage 1 (0, 4, and 8 weeks), Stage 2 (11 weeks),
and Stage 3 (13 weeks; Fig. 1). RT-PCR was done as
previously described (Sundberg et al., 2009). See supple-
mental information and Supplemental Table 1 for analyzed
genes and their primer sequences. Quantitative RT-PCR
(qRT-PCR) was performed with a TaqMan assay (Applied
Biosystems, Foster City, CA, USA) for Olig2 and GAPHD using
the Applied Biosystems 7300 Real-Time PCR System (Applied
Biosystems). See supplemental information for details.Cell proliferation
Adherent cultures of OPCs from Stage 2 (11 weeks) were
incubated with 10 µM 5′-bromo-2-deoxyuridine (BrdU,
Sigma) in Medium 2.1, 2.2, 2.3, or 2.4 for 12 h. Thereafter,
cells were fixed with 4% paraformaldehyde (PFA) for 20 min,
washed with PBS, treated with 2 M HCl at room temperature
for 30 min, and neutralized with 0.1 M sodium borate (pH
8.5) for 2 min. See immunocytochemical characterization
section for details.
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OPC spheres from Stage 2 (11 weeks) were dissected into
single cell suspensions with 0.05×trypsin-EDTA (BioWhit-
taker, Fisher Scientific Inc., Leicestershire, UK) and plated
on poly-D-ornithine- (50 µg/ml in PBS) coated 24-well plates
in Medium 2.1, 2.2, 2.3, or 2.4. After 2 to 3 h, calcein-AM and
ethidium homodimer-1 were added to the medium and
incubated with cells for 30 min; the protocol was modified
from manufacturer's instructions (LIVE/DEAD viability/cyto-
toxicity Kit for mammalian cells, Molecular Probes, Invitro-
gen). See supplemental information.
Immunocytochemical characterization
Differentiating oligodendrocytes in adherent cultures at
Stages 1–3 (4, 8, 11, and 12 weeks) were characterized
immunocytochemically. Briefly, cells were fixed with 4% PFA
for 10 min at room temperature and washed twice with PBS.
For blocking 10% NDS and 1% BSA in PBS (containing 0.1% Triton
X-100 for detection of intracellular proteins) were used.
Primary antibodies were diluted in 1% BSA and 1% NDS in PBS
(containing 0.1% Triton X-100 for detection of intracellular
proteins) and incubated with cells overnight at 4 °C. Second-
ary antibodies were diluted in 1% BSA in PBS and incubated
with cells for 1 h at room temperature in the dark. Cells were
thenwashedwith PBS and with phosphate buffer andmounted
with Vectashield containing DAPI. See list of used antibodies
and description of cell counting in supplemental information.
Flow cytometric analysis
Flow cytometric analysis of differentiating OPCs was
performed at Stages 1 (4 or 8 weeks), 2 (11 weeks), and 3
(12 weeks; see Fig. 1). Sample preparation was performed
using a modified method from (Sundberg et al., 2009); see
supplemental information for details.
Coculture of OPCs with hESC-derived neurons
After 11 weeks of differentiation, the OPCs from Stage 2 were
coculturedwith green fluorescent protein (GFP)-labeled hESC
neurons differentiated as described previously (Sundberg et
al., 2009). The neuronal cells were transduced with LV-PGK-
GFP at a multiplicity of infection of 30 for 5 h at 37 °C (a kind
gift from Professor Seppo Ylä-Herttuala, University of Kuopio,
Finland). After 1 week, the mechanically split hESC-derived
OPC spheres were plated with GFP-labeled neurons and
cultured in Medium 2.1 for 2 weeks. Cultures were double-
stained for GalC and MBP as described above. The HS360 line
was used for these analyses. For electron microscopy
analyses, OPCs (Stage 3) and neurons were cocultured on 4-
well Lab-Tek Chamber Slides (Nunc Corporation, Denmark) in
Medium 3.2 supplemented with 1X B27 for 2 weeks. See
supplemental information for detail sample preparation.
NG2+ cell sorting, subculturing, and analysis
Cell sorting of NG2+ cells (Stage 2, 11 weeks) with FACSAria
was performed as previously described (Sundberg et al.,2009); see supplemental information. After sorting NG2+
cells were subjected to proliferation assay, sphere forma-
tion assay, and for in vitro differentiation. The sorted cells
were characterized using RT-PCR, flow cytometry, and
immunocytochemistry. See supplemental information for
details.
Statistical analysis
SPSS for Windows (v. 16.0, SPSS Inc., Chicago, IL) was used
for statistical analysis. Nonparametric Kruskal-Wallis test
followed by Mann-Whitney U test were used for all analyses.
P values of less than 0.05 were considered statistically
significant.
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